Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleNEUROPHARMACOLOGY

Selective Agonism of Group I P2X Receptors by Dinucleotides Dependent on a Single Adenine Moiety

Okan Cinkilic, Brian F. King, Markus van der Giet, Hartmut Schlüter, Walter Zidek and Geoffrey Burnstock
Journal of Pharmacology and Experimental Therapeutics October 2001, 299 (1) 131-136;
Okan Cinkilic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brian F. King
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Markus van der Giet
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hartmut Schlüter
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Walter Zidek
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Geoffrey Burnstock
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

We have investigated the activity of naturally occurring high-performance liquid chromatography-purified diadenosine polyphosphates (ApnA, n = 5–6), adenosine polyphospho guanosines (ApnG,n = 5–6), and diguanosine polyphosphates (GpnG, n = 5–6) under voltage-clamp conditions at recombinant rat P2X1–4 purinoceptor subtypes expressed in Xenopuslaevis oocytes. At rP2X1 and rP2X3 receptors, ApnAs and ApnGs evoked concentration-dependent inward currents. GpnGs were not active at these receptors. At rP2X2 and rP2X4 receptors, dinucleotides did not show significant activity. For the rP2X1 receptor, ApnAs and ApnGs were partial agonists; for the P2X3 receptor, only Ap5G was full agonist, whereas the other tested substances were partial agonists. The rank order of potency at rP2X1 was ATP ≥ Ap6A ≥ Ap5A ≥ Ap6G ≥ Ap5G, and rank order of efficacy was ATP ≥ Ap5A ≥ Ap6A > Ap5G > Ap6G, whereas at rP2X3 the rank order of potency was ATP > Ap5G ≥ Ap5A ≥ Ap6A ≥ Ap6G and the rank order of efficacy was ATP ≈ Ap5G ≥ Ap5A ≈ Ap6A ≥ Ap6G. For rP2X1 and rP2X3 it is evident that receptor agonism depended on the presence of at least one adenine moiety in the dinucleotide, while the presence of a guanine moiety had a significant impact and decreased agonist efficacy. The data suggest that naturally occurring ApnAs and ApnGs may play an important physiological role in different human tissues and systems by activating group I P2X receptors.

Footnotes

  • This work was supported by the Deutsche Forschungs-gemeinschatft (Grant Schl 406/1-2) and by Roche Bioscience.

  • Abbreviations:
    ApnA
    diadenosine polyphosphate
    ApnG
    polyphospho guanosine
    Ap6A
    diadenosine hexaphosphate
    α
    β-meATP, α, β-methylene-adenosine 5'-triphosphate
    GpnG
    diguanosine polyphosphate
    Ap5A
    diadenosine pentaphosphate
    Ap5G
    adenosine pentaphospho guanosine
    Ap6G
    adenosine hexaphospho guanosine
    Gp5G
    diguanosine pentaphosphate
    Gp6G
    diguanosine hexaphosphate
    • Received February 28, 2001.
    • Accepted June 11, 2001.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 299 (1)
Journal of Pharmacology and Experimental Therapeutics
Vol. 299, Issue 1
1 Oct 2001
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Selective Agonism of Group I P2X Receptors by Dinucleotides Dependent on a Single Adenine Moiety
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleNEUROPHARMACOLOGY

Selective Agonism of Group I P2X Receptors by Dinucleotides Dependent on a Single Adenine Moiety

Okan Cinkilic, Brian F. King, Markus van der Giet, Hartmut Schlüter, Walter Zidek and Geoffrey Burnstock
Journal of Pharmacology and Experimental Therapeutics October 1, 2001, 299 (1) 131-136;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleNEUROPHARMACOLOGY

Selective Agonism of Group I P2X Receptors by Dinucleotides Dependent on a Single Adenine Moiety

Okan Cinkilic, Brian F. King, Markus van der Giet, Hartmut Schlüter, Walter Zidek and Geoffrey Burnstock
Journal of Pharmacology and Experimental Therapeutics October 1, 2001, 299 (1) 131-136;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Antipsychotic-VMAT2 Inhibitor Synergy: Schizophrenia Models
  • Rescue Pharmacology on Disease-Related GRIN Variants
  • Obesity thwarts preconditioning in TBI
Show more Neuropharmacology

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics